tiprankstipranks
Omega Therapeutics (OMGA)
NASDAQ:OMGA
US Market

Omega Therapeutics (OMGA) Financial Statements

257 Followers

Omega Therapeutics Financial Overview

Omega Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.085; its P/E ratio is -1.63; Omega Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 831.00K$ 759.00K$ 516.00K$ 734.00K$ 595.00K
Gross Profit$ 1.44M$ 378.00K$ 104.00K$ -205.00K-
EBIT$ -22.46M$ -30.20M$ -26.38M$ -32.06M$ -25.98M
EBITDA-$ 0.00$ -25.02M$ -27.84M$ -25.59M
Net Income Common Stockholders$ -22.25M$ -29.69M$ -25.28M$ -30.83M$ -25.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 89.30M$ 112.98M$ 136.79M$ 124.68M$ 148.35M
Total Assets$ 217.81M$ 229.05M$ 156.31M$ 141.84M$ 170.06M
Total Debt$ 131.20M$ 118.63M$ 22.23M$ 22.53M$ 22.89M
Net Debt$ 41.90M$ 5.65M$ -114.55M$ -102.14M$ -125.46M
Total Liabilities$ 141.76M$ 133.11M$ 33.31M$ 145.95M$ 36.41M
Stockholders Equity$ 76.04M$ 95.92M$ 123.00M$ 105.97M$ 133.65M
Cash Flow-
Free Cash Flow--$ -28.08M$ -24.51M$ -25.16M
Operating Cash Flow$ -23.00M-$ -28.08M$ -24.22M$ -24.84M
Investing Cash Flow$ -724.00K-$ 22.05M$ 17.65M$ 10.59M
Financing Cash Flow$ -8.00K-$ 39.99M$ 586.00K$ 4.00K
Currency in USD

Omega Therapeutics Earnings and Revenue History

Omega Therapeutics Debt to Assets

Omega Therapeutics Cash Flow

Omega Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis